How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

• Main Authors: Ru Han (Author), Jorge A. Gomez (Author), Bruna de Veras (Author), Thatiana Pinto (Author), Adriana Guzman-Holst (Author), Javier Nieto (Author), Désirée A. M. van Oorschot (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study aimed to: (1) estimate the disease burden of herpes zoster (HZ) and (2) assess the potential public health impact of introducing adjuvanted recombinant zoster vaccine (RZV) compared with no vaccination in adults aged ≥50 years in Argentina, Brazil, Mexico, Chile, and Colombia using the ZO...